Tracer library / [67Cu]Cu-pertuzumab-PEG6-DM1

[67Cu]Cu-pertuzumab-PEG6-DM1

Also written as [Cu-67]Cu-pertuzumab-PEG6-DM1

Radionuclide: Cu-67 t½ 3708 min
Modality: Therapy
Production route: —
Stage: Reported once
Syntheses indexed: 0

Breast cancer

What it is

Compound class: Antibody-drug conjugate (pertuzumab-PEG6-DM1)
Target / mechanism: HER2-targeting via pertuzumab (domain II) antibody-drug conjugate PMID 37095184
Clinical application: Breast cancer (HER2-overexpressing breast cancer) theranostics PMID 37095184
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [67Cu]Cu-pertuzumab-PEG6-DM1, or handle the enquiry for you.

Get in touch

Notes

Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 37095184. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 37095184: 'pertuzumab-PEG6-DM1'.